32973044|t|14,15-Epoxyeicosatrienoic Acid Alleviates Pathology in a Mouse Model of Alzheimer's Disease.
32973044|a|Alzheimer's disease (AD) is the leading cause of late-onset dementia, and there exists an unmet medical need for effective treatments for AD. The accumulation of neurotoxic amyloid-beta (Abeta) plaques contributes to the pathophysiology of AD. EPHX2 encoding soluble epoxide hydrolase (sEH)-a key enzyme for epoxyeicosatrienoic acid (EET) signaling that is mainly expressed in lysosomes of astrocytes in the adult brain-is cosited at a locus associated with AD, but it is unclear whether and how it contributes to the pathophysiology of AD. In this report, we show that the pharmacologic inhibition of sEH with 1-trifluoromethoxyphenyl- 3-(1-propionylpiperidin-4-yl) urea (TPPU) or the genetic deletion of Ephx2 reduces Abeta deposition in the brains of both male and female familial Alzheimer's disease (5xFAD) model mice. The inhibition of sEH with TPPU or the genetic deletion of Ephx2 alleviated cognitive deficits and prevented astrocyte reactivation in the brains of 6-month-old male 5xFAD mice. 14,15-EET levels in the brains of these mice were also increased by sEH inhibition. In cultured adult astrocytes treated with TPPU or 14,15-EET, astrocyte Abeta clearance was increased through enhanced lysosomal biogenesis. Infusion of 14,15-EET into the hippocampus of 5xFAD mice prevented the aggregation of Abeta. Notably, a higher concentration of 14,15-EET (200 ng/ml) infusion into the hippocampus reversed Abeta deposition in the brains of 6-month-old male 5xFAD mice. These results indicate that EET signaling, especially 14,15-EET, plays a key role in the pathophysiology of AD, and that targeting this pathway is a potential therapeutic strategy for the treatment of AD.SIGNIFICANCE STATEMENT There are limited treatment options for Alzheimer's disease (AD). EPHX2 encoding soluble epoxide hydrolase (sEH) is located at a locus that is linked to late-onset AD, but its contribution to the pathophysiology of AD is unclear. Here, we demonstrate that sEH inhibition or Ephx2 deletion alleviates pathology in familial Alzheimer's disease (5xFAD) mice. Inhibiting sEH or increasing 14,15-epoxyeicosatrienoic acid (EET) enhanced lysosomal biogenesis and amyloid-beta (Abeta) clearance in cultured adult astrocytes. Moreover, the infusion of 14,15-EET into the hippocampus of 5xFAD mice not only prevented the aggregation of Abeta, but also reversed the deposition of Abeta. Thus, 14,15-EET plays a key role in the pathophysiology of AD and therapeutic strategies that target this pathway may be an effective treatment.
32973044	0	30	14,15-Epoxyeicosatrienoic Acid	Chemical	MESH:C046782
32973044	57	62	Mouse	Species	10090
32973044	72	91	Alzheimer's Disease	Disease	MESH:D000544
32973044	93	112	Alzheimer's disease	Disease	MESH:D000544
32973044	114	116	AD	Disease	MESH:D000544
32973044	153	161	dementia	Disease	MESH:D003704
32973044	231	233	AD	Disease	MESH:D000544
32973044	255	265	neurotoxic	Disease	MESH:D020258
32973044	280	285	Abeta	Gene	11820
32973044	333	335	AD	Disease	MESH:D000544
32973044	337	342	EPHX2	Gene	13850
32973044	352	377	soluble epoxide hydrolase	Gene	13850
32973044	379	382	sEH	Gene	13850
32973044	401	425	epoxyeicosatrienoic acid	Chemical	-
32973044	427	430	EET	Chemical	-
32973044	551	553	AD	Disease	MESH:D000544
32973044	630	632	AD	Disease	MESH:D000544
32973044	695	698	sEH	Gene	13850
32973044	704	764	1-trifluoromethoxyphenyl- 3-(1-propionylpiperidin-4-yl) urea	Chemical	-
32973044	766	770	TPPU	Chemical	-
32973044	799	804	Ephx2	Gene	13850
32973044	813	818	Abeta	Gene	11820
32973044	868	896	familial Alzheimer's disease	Disease	MESH:D000544
32973044	898	903	5xFAD	Disease	
32973044	911	915	mice	Species	10090
32973044	935	938	sEH	Gene	13850
32973044	944	948	TPPU	Chemical	-
32973044	976	981	Ephx2	Gene	13850
32973044	993	1011	cognitive deficits	Disease	MESH:D003072
32973044	1083	1088	5xFAD	Disease	
32973044	1089	1093	mice	Species	10090
32973044	1095	1104	14,15-EET	Chemical	MESH:C046782
32973044	1135	1139	mice	Species	10090
32973044	1163	1166	sEH	Gene	13850
32973044	1221	1225	TPPU	Chemical	-
32973044	1229	1238	14,15-EET	Chemical	MESH:C046782
32973044	1250	1255	Abeta	Gene	11820
32973044	1331	1340	14,15-EET	Chemical	MESH:C046782
32973044	1365	1370	5xFAD	Disease	
32973044	1371	1375	mice	Species	10090
32973044	1405	1410	Abeta	Gene	11820
32973044	1447	1456	14,15-EET	Chemical	MESH:C046782
32973044	1508	1513	Abeta	Gene	11820
32973044	1559	1564	5xFAD	Disease	
32973044	1565	1569	mice	Species	10090
32973044	1599	1602	EET	Chemical	-
32973044	1679	1681	AD	Disease	MESH:D000544
32973044	1772	1787	AD.SIGNIFICANCE	Disease	MESH:D000544
32973044	1838	1857	Alzheimer's disease	Disease	MESH:D000544
32973044	1859	1861	AD	Disease	MESH:D000544
32973044	1864	1869	EPHX2	Gene	13850
32973044	1879	1904	soluble epoxide hydrolase	Gene	13850
32973044	1906	1909	sEH	Gene	13850
32973044	1962	1964	AD	Disease	MESH:D000544
32973044	2013	2015	AD	Disease	MESH:D000544
32973044	2054	2057	sEH	Gene	13850
32973044	2072	2077	Ephx2	Gene	13850
32973044	2111	2139	familial Alzheimer's disease	Disease	MESH:D000544
32973044	2141	2146	5xFAD	Disease	
32973044	2148	2152	mice	Species	10090
32973044	2165	2168	sEH	Gene	13850
32973044	2183	2213	14,15-epoxyeicosatrienoic acid	Chemical	MESH:C046782
32973044	2215	2218	EET	Chemical	-
32973044	2268	2273	Abeta	Gene	11820
32973044	2341	2350	14,15-EET	Chemical	MESH:C046782
32973044	2375	2380	5xFAD	Disease	
32973044	2381	2385	mice	Species	10090
32973044	2424	2429	Abeta	Gene	11820
32973044	2467	2472	Abeta	Gene	11820
32973044	2533	2535	AD	Disease	MESH:D000544
32973044	Negative_Correlation	MESH:C046782	11820
32973044	Association	MESH:D000544	13850
32973044	Positive_Correlation	MESH:D000544	11820
32973044	Negative_Correlation	MESH:C046782	13850
32973044	Negative_Correlation	MESH:C046782	MESH:D000544
32973044	Negative_Correlation	MESH:D003072	13850

